4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-064052
Chief Executive Officer sold 5,149 shares at $0.79 ($4,080)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-21 | Sale : show line 1 in the form | −5,149 | $0.79 | $4,080 | 784,471 | D |
| Open-market sales · 5,149 sh · avg $0.79 · $4,080 | ||||||
Loading xslF345X05/ownership.xml…